Medical Devices

Urolution Medical's FDA-cleared OpenFlo catheter challenges a century-old design, aiming to slash hospital infections without inflating supply chain costs.

The AMA's Category I CPT code approval for Vektor Medical's vMap signals a major shift, turning computational ECGs into commercial reality.

With a new $125M Series D, Medical Microinstruments is moving robotics into the sub-millimeter realm, targeting lymphatic repair and Alzheimer's disease.

Alpheus Medical's new clinical trial tackles butterfly glioblastoma, leveraging non-invasive ultrasound and strategic financing to disrupt oncology.

As wearables pivot from consumer gadgets to clinical tools, Oura’s new ISO 13485 certification lays the groundwork for regulated medical features.

Medela's new Drainology hub aims to standardize post-op chest drainage, highlighting the growing economic influence of medtech in clinical education.

As the BCI race intensifies, Europe’s MINIGRAPH consortium unveils a magnetically guided, graphene-based implant that navigates curved brain pathways.

Lindsay Boyle's move to Blink Anesthesia signals a massive commercial shift as new clinical guidelines force hospitals to upgrade surgical monitoring tech.

As biopharma pivots to high-dose subcutaneous therapies, conventional delivery systems are hitting a mechanical wall. Early 'systems thinking' is the new mandate.

Datasea’s FY2026 results reveal a bold strategy: slashing low-margin revenue by 43% to drive a 70% gross profit increase and fund a pivot to acoustic AI.

By automating point-of-care diagnostics, Antech’s new trūRapid Reader aims to capture high-margin consumable sales while curing clinical workflow headaches.

As Resmed prepares to report its Q1 FY2027 earnings, investors are watching how the medical device giant navigates GLP-1 disruptions and AI-driven growth.

The AMA's approval of Category I codes for single-lead neurostimulators marks a massive operational shift for sleep apnea care and clinical adoption.

BioCardia’s revised FDA submission for its Helix catheter could set a new regulatory standard and unlock lucrative biopharma partnerships.

A new peer-reviewed study validates RenovoRx's targeted catheter platform, offering a strategic bridge as the company approaches its 2027 Phase III readout.

ViCentra's latest real-world data reveals exceptional glucose control, positioning its design-first Kaleido pump to challenge major medtech incumbents.

Johnson & Johnson’s new eye health campaign highlights a hidden menopause symptom, revealing a calculated push to capture a booming demographic market.

As Eve Wellness opens its second Bay Area clinic, the direct-to-consumer model sparks debate over AI ultrasound, patient autonomy, and false positives.

New clinical data reveals how dynamic perfusion technology is preventing catastrophic bedsores in critically ill ECMO patients and saving hospitals millions.

A new campaign highlights how pre-packaging surgical trays to save ten minutes of prep time could alleviate the structural crisis facing European hospitals.